Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses.
Mechanisms underlying the virulence of H5N1 influenza viruses in humans are poorly understood, though evidence of hyperinflammation and systemic viral replication has been reported. Plasmacytoid dendritic cells (PDCs), a major source of type I interferon, potentially affect host defense against influenza viruses. To analyze how influenza virus infection alters PDC function, we measured cytokine secretion from primary human PDCs infected with high- or low-pathogenicity influenza viruses. IFN-alpha responses induced by H5N1 viruses were several-fold higher than those induced by low-pathogenicity strains; differences in the secretion of the proinflammatory cytokines TNF-alpha and IP-10 were less pronounced, in contrast with findings from human macrophage studies. Reassortant viruses bearing H5N1-derived NS genes did not elicit enhanced IFN-alpha secretion by PDCs; thus, other H5N1 gene(s) are responsible for the heightened response. Their central role in the induction of an effective antiviral immune response and the finding that they respond differently to influenza viruses of different pathogenicities suggest that PDCs may play a role in the hypercytokinemia associated with H5N1 infection in humans.
Sandbulte
Matthew R
MR
Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Boon
Adrianus C M
AC
Webby
Richard J
RJ
Riberdy
Janice M
JM
D016207:Cytokines / Q000378:metabolism*; D003713:Dendritic Cells / Q000378:metabolism* / Q000821:virology*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D009980:Influenza A virus / Q000235:genetics / Q000472:pathogenicity*; D007251:Influenza, Human / Q000276:immunology; D007370:Interferon Type I / Q000378:metabolism; D016898:Interferon-alpha / Q000378:metabolism; D009976:Orthomyxoviridae Infections / Q000378:metabolism*; D016865:Reassortant Viruses / Q000378:metabolism; D017361:Viral Nonstructural Proteins / Q000378:metabolism
D016207:Cytokines; C085820:INS1 protein, influenza virus; D007370:Interferon Type I; D016898:Interferon-alpha; D017361:Viral Nonstructural Proteins
Emerg Infect Dis. 2005 Jul;11(7):1036-41
16022777
J Virol. 2005 Jun;79(12):7535-43
15919908
J Immunol. 2006 Apr 1;176(7):4343-51
16547272
J Exp Med. 2006 Mar 20;203(3):689-97
16533883
Virology. 2006 Mar 30;347(1):52-64
16378631
Immunol Cell Biol. 2006 Jun;84(3):267-73
16509829
J Infect Dis. 2006 Jul 1;194(1):61-70
16741883
BMC Infect Dis. 2006;6:87
16725022
Nat Med. 2006 Oct;12(10):1203-7
16964257
J Virol. 2007 Mar;81(5):2318-27
17182679
J Virol. 2007 Sep;81(18):9790-800
17626092
J Immunol. 2007 Oct 15;179(8):5220-7
17911607
Respir Res. 2005;6:135
16283933
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
10801978
J Virol. 2000 Dec;74(24):11566-73
11090154
J Med Virol. 2001 Mar;63(3):242-6
11170064
Nat Immunol. 2000 Oct;1(4):305-10
11017101
Arch Virol. 2001 Dec;146(12):2275-89
11811679
Vaccine. 2002 Aug 19;20(25-26):3165-70
12163268
Nat Med. 2002 Sep;8(9):950-4
12195436
Lancet. 2002 Dec 7;360(9348):1831-7
12480361
Nature. 2003 Jul 17;424(6946):324-8
12819664
Immunity. 2003 Aug;19(2):225-34
12932356
Lancet. 2004 Feb 21;363(9409):617-9
14987888
Science. 2004 Mar 5;303(5663):1529-31
14976261
J Immunol. 2004 Apr 1;172(7):4253-9
15034038
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8156-61
15148370
Science. 1999 Jun 11;284(5421):1835-7
10364556
Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67
13465720
J Immunol. 2004 Nov 15;173(10):5935-43
15528327
Am J Respir Cell Mol Biol. 2005 Mar;32(3):177-84
15576669
N Engl J Med. 2005 Feb 17;352(7):686-91
15716562
J Infect Dis. 2005 Apr 1;191(7):1105-15
15747246
J Exp Med. 2005 Aug 15;202(4):461-5
16103406